Canada Pension Plan Investment Board Sells 8,000 Shares of Azenta, Inc. (NASDAQ:AZTA)

Canada Pension Plan Investment Board lessened its holdings in Azenta, Inc. (NASDAQ:AZTA) by 44.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,800 shares of the company’s stock after selling 8,000 shares during the period. Canada Pension Plan Investment Board’s holdings in Azenta were worth $516,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Hantz Financial Services Inc. bought a new stake in Azenta in the 2nd quarter valued at $30,000. Benjamin F. Edwards & Company Inc. acquired a new position in Azenta in the 1st quarter valued at $38,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Azenta in the 1st quarter valued at $49,000. Lazard Asset Management LLC acquired a new position in Azenta in the 1st quarter valued at $130,000. Finally, Acadian Asset Management LLC grew its holdings in Azenta by 24.7% in the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock valued at $143,000 after buying an additional 471 shares in the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

AZTA opened at $49.38 on Friday. The firm has a market cap of $2.66 billion, a P/E ratio of -18.22 and a beta of 1.47. Azenta, Inc. has a 52-week low of $44.00 and a 52-week high of $69.16. The business’s fifty day moving average is $51.77 and its 200-day moving average is $53.42.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.09. The company had revenue of $173.00 million for the quarter, compared to analyst estimates of $166.14 million. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. Azenta’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.13 EPS. On average, research analysts predict that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $69.00 price objective on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI upped their price objective on Azenta from $52.00 to $53.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Azenta currently has an average rating of “Hold” and an average price target of $67.00.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.